What is PharPoint Research?
PharPoint Research operates as a privately owned contract research organization (CRO) based in the US. The company specializes in providing agile and efficient drug development solutions tailored to clients across various scales, from emerging biotechs to established pharmaceutical enterprises. Its core competency lies in navigating the complex regulatory and scientific pathways of bringing new therapies to market.
How much funding has PharPoint Research raised?
PharPoint Research has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in PharPoint Research
PPP
Public-Private Partnership
What's next for PharPoint Research?
The recent major strategic investment signals a pivotal moment for PharPoint Research, likely enabling expansion of its service offerings, enhancement of its technological infrastructure, or broader market penetration. As a CRO in the enterprise-level funding stage, PharPoint Research is positioned to further solidify its role as a key partner in the pharmaceutical and biotechnology industries, potentially accelerating the development timelines for its clients' drug candidates and contributing to advancements in therapeutic innovation.
See full PharPoint Research company page